Clinical trial · Observational
Comprehensive Demographics and Clinical Profile of NSCLC Patients
Comprehensive Demographics and Clinical Profile of NSCLC Patients: Analyzing Treatment Patterns With PD-L1 Stratification
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Advances in the treatment of non-small cell lung cancer in the last decade have been significant. Currently, there are several first-line therapeutic options. The molecular biology of the disease, biomarkers and the patient's clinical characteristics can assist in decision making. The study in question aims to retrospectively evaluate the patterns of choice in the first line treatment of metastatic non-small cell lung cancer without driver mutations, from 2019 to 2022 in 7 centers in Brazil.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer Non Small Cell | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- treatment regimen decision option one
- timeFrame
- In 30 days
- description
- immunotherapy versus chemotherapy, this outcome will be evaluated based on data from medical records and available laboratory results
- measure
- treatment regimen decision option two
- timeFrame
- In 30 days
- description
- dual immunotherapy, this outcome will be evaluated based on data from medical records and available laboratory results
Secondary outcomes (1)
- measure
- Survival analysis
- timeFrame
- In 24 months
- description
- Survival will be analyzed secondarily, using the variable time to death
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Over 18 years old; * Histological diagnosis of advanced non-small cell cancer; * Clinical and demographic data available in medical records; Exclusion Criteria: * Patients with localized disease that can be treated locally; * Non-epithelial histology; * small cell carcinoma * neuroendocrine tumor
References
Publications (0)
Data not yet available